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Abstract

In situ hybridization, in situ transcription, and in
situ polymerase chain reaction (PCR) are techniques
used to detect DNA and RNA sequences within a cell or
tissue structure. These three in situ methodologies
employ the principles of recombinant DNA to form
double-stranded hybrids of DNA-DNA, DNA-RNA, or
RNA-RNA. The essence of in situ hybridization (ISH)
is the hybridization of a labeled probe to a complementary target sequence, whereas in situ transcription
(1ST) is the synthesis of complementary DNA incorporating a label directly on the target DNA or RNA within
a cell or tissue. In the case of in situ PCR (ISPCR), it
is the repeated in situ duplication of both the sense and
antisense strands of DNA to increase the number of
copies of the target sequence. ISH, 1ST, and ISPCR
each have their advantages and disadvantages. The
purpose of this chapter is to address in situ considerations requried of these techniques, emphasizing tissue
fixation, pre-hybridization steps, DNA probes, RNA
probes, oligoprobes, and probe labeling. Five successfully used protocols are presented as examples. Any
given nucleotide target sequence may have its own
unique set of optimum conditions, thus requiring some
adjustment in the hands of the user.
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L.E. De Bault and J. Gu
The essence of in situ PCR (ISPCR) is repeated in
situ transcriptions of both the sense and antisense strands
of DNA to increase the number of copies of the target
sequence. In its simplest form, ISPCR is performed by
denaturing double-stranded nucleic acids to singlestrands, two primers bracketing a sequence of interest
are hybridized to their targets, the sequence amplified
with PCR, and the amplicons detected. The advantages
of ISPCR and the need for controls will be discussed.
For more detailed discussion of these techniques, readers
are referred to the monographs and reviews published on
the topics [14, 16, 58, 63, 75].

Introduction

In situ hybridization, in situ transcription, and in
situ polymerase chain reaction (PCR) are techniques
used to detect DNA and RNA sequences in chromosomes, cells or intact tissue sections. These three in situ
methodologies employ the principles of recombinant
DNA (rtDNA) as they are broadly defined [49), and rely
on the powerful and widely used technique of nucleic
acid hybridization which exploits the ability of complementary sequences in single-stranded DNAs and RNAs
to pair with each other to form double-stranded hybrids
of DNA-DNA, DNA-RNA, or RNA-RNA. Man-made
sequences of nucleotide that specifically bond or hybridize to a target sequence in an A-T (or U) and C-G
complementary fashion are called DNA or RNA probes.
In the in situ hybridization technique, the probes are
labeled with a radioisotope or chemically tagged for the
detection and localization of the hybridized probes. The
hybridized probes are then detected by either a direct or
indirect method. In the in situ transcription technique,
an unlabeled probe is used as a primer and labeled
nucleotides are incorporated into the cDNA that is
synthesized as the primer is extended on the target
template. In the case of in situ PCR, the target sequences are bracketed by two primers and are amplified by
making a large number of copies, and then the copies
are detected or directly visualized.

Historical background
ISH, IST, and ISPCR, like other scientific tools and
the new knowledge they provide, were preceded by
other key discoveries and innovations.
From our
perspective, there were about a dozen or so historic
milestones spanning approximately two decades which
made molecular biology possible and the application of
ISH, 1ST, and ISPCR to tissues and cells in situ,
practical. The 1969 work of Gall and Pardue [24),
demonstrating the formation and detection of RNA-DNA
hybrid molecules in situ, were proof-of-principle findings that made the ISH technique possible. In 1970, the
discovery of RNA-dependent DNA polymerase (or
reverse transcriptase) by two independent groups,
Baltimore [5] and Ternin and Mizutani [88), and the
1971 work of Kleppe et al. [51] demonstrating the
replication of short synthetic DNA segments catalyzed
by DNA polymerases, demonstrated the possibility of
1ST. But it was not until Langer et al. [59) enzymatically synthesized Biotin-labeled polynucleotides, followed
by the work of Saiki et al. in 1985 [82) that achieved in
vitro primer-mediated amplification of genomic DNA,
that practical 1ST was made possible. The 1ST technique was first described and applied to tissue sections
by Tecott et al. in 1988 [87) and was confirmed and
applied to cells in vitro by Longley et al. in 1989 [67).
The field picked up steam with three landmark discoveries: i.e., the 1973 work of Cohen et al. [17) demonstrating the cloning DNA fragments into plasmid vectors, the
1975 work of Kohler and Milstein [57] demonstrating
the development and in vitro production of monoclonal
antibodies, and the 1976 work of Chien et al. [15]
discovering thermostable DNA polymerase. This was
later followed in 1987 by Kogan et al. [56] who introduced the use of thermostable DNA polymerase and
made possible the practical use of the polymerase chain
reaction (PCR). The introduction of liquid phase PCR
and its automation dramatically improved the rate of
progress for molecular biology [77]. The aforementioned milestones were essential advances for the advent
of ISH, IST, and ISPCR, and were indirectly necessary

The essence of in situ techniques
The essence of in situ hybridization (ISH) is the
hybridization of a labeled probe to a complementary
target sequence. In its simplest form, ISH is performed
by separating the strands of double-stranded nucleic
acids by denaturing, hybridizing a labeled probe to its
complementary DNA or RNA in tissue sections or
individual cells, washing away the unhybridized probe,
and detecting the label on the bound probe. Protocols
will be presented that will take advantage of simplicity
and directness of ISH. The advantages and disadvantages of ISH and the need for controls will be discussed.
The essence of in situ transcription (1ST) is the
synthesis of complementary DNA (cDNA) within a cell.
In its simplest form, IST is performed by annealing a
specific unlabeled primer to its complementary mRNA
in a tissue section or individual cell, washing away the
unhybridized primer, and synthesizing cDNA in the
presence of reverse transcriptase and deoxynucleotide
triphosphates (dNTPs), some of which are labeled.
Protocols will be presented that take advantage of the
simplicity of IST, the use of Digoxigenin (DIG)-labeled
dUTP and an immunochemical bridge. The advantages
and disadvantages of IST and Immunogold Silver
Staining (IGSS) will be discussed.
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and proceed with the hybridization steps. We have also
found that it may be beneficial to let the samples dry
after the equilibrate washing and applying the hybridization cocktail directly on the dry samples. When nonspecific background staining is controlled, this usually gives
stronger signals, presumably because of a better penetration of the probes to the tissue sample and a more
controlled concentration of the salts in the immediate
environment of the hybridization reaction.

for the proof-of-principles of these in situ techniques.

Scope of Chapter
Many names have been given to these techniques
encompassing a wide range of protocols, but the principles remain the same. In this chapter, we give a concise
and comprehensive review of the principles and procedures of these techniques and their major variations. As
examples, certain protocols that have been tested by the
authors are included at the end of this chapter.

DNA probes
The key in probe design and selection is that the
probe sequence has to be specific to the target and not
complementary to any other sequence. Double-stranded
DNA probes were the initial approach developed for in
situ hybridization because of their relative stability.
They can, however, be destroyed by DNase which
requires magnesium to function and can be inhibited by
EDTA [80). They are usually labeled by nick translation or random primer extension. These probes can be
as long as a few thousand nucleotides or as short as 1 or
2 dozen nucleotides [80). Double-stranded probes must
be denatured before hybridization, which is generally
achieved by increasing the temperature. The drawback
of double-stranded probes is that the two strands tend to
re-anneal to themselves during hybridization, thereby
decreasing the detecting efficiency.
Single-stranded
DNA probes can also be produced by using the 13M
cloning vectors [42, 72) and PCR [68), overcoming the
disadvantage of probe re-annealing. Thus, they are
more efficient at hybridizing to their targets than doublestranded probes [78).

In situ Conditions
General considerations

In vivo nucleotide sequences anneal and separate
with a high degree of precision. In vitro their behavior
also follows certain general rules. The factors that
affect their behavior the most include temperature, salt
concentration, length of the probes, percentage of C-G
content, pH and concentrations of certain chemicals such
as formamide. Changing the temperature or pH are the
most commonly used methods to manipulate the annealing and denaturation of DNA or RNA [16).
Fixation
The most commonly used fixatives for in situ
hybridization have been aldehyde-based fixatives such as
10% formalin or 4% paraformaldehyde [14). The
aldehyde fixatives cross link proteins, or proteins and
nucleotides, and effectively preserve the nucleotide
sequence. Fixatives with picric acid such as Bouin's
fixative or heavy metals such as Zenker's solution
should be avoided as damage of target nucleotide
sequences may occur [27). Fixation from three hours to
overnight appears to be an acceptable range depending
on the size and nature of the tissue and the strength of
the fixation. Frozen sections can also be used.

RNA probes
A riboprobe is a single-stranded RNA probe produced by cloning man-made vectors containing promoters and an insert of cDNA fragment of interest at a
known orientation [47, 71, 85). The recombinant
plasmid vectors can be grown and amplified in appropriate bacterial hosts, whereby the inserted cDNA grows in
quantity. The inserted sequences are then transcribed
with RNA polymerase into RNA probes. Radioisotope
or other labeling molecules can be incorporated during
transcription.
By reversing the orientation of the
inserted cDNA, both anti-sense and sense RNA probes
can be produced. A "sense" probe refers to a sequence
equivalent to the target mRNA and an "antisense" probe
is complementary to the sequence and is used to hybridize with the target. Riboprobes are superior to DNA
probes in that they are single-stranded and do not
reanneal to themselves, resulting in a more efficient
target detection [3, 18, 64, 80). When hybridized to
mRNA, it is more stable than DNA-RNA hybridization
and can stand stringent hybridization conditions and
washing [44). Following hybridization, it is possible to

Pre-hybridization steps
The aldehyde-fixed samples need to be digested to
expose the targets, yet this digestion should be optimized
to also preserve the morphology and retain the target
sequences after hybridization. Proteinase K, trypsin,
pronase and other proteases have all been used successfully. The digested sections should be washed thoroughly to remove or inactivate all the enzymes. A prehybridization step is recommended which should eliminate or reduce the background nonspecific reactions.
This usually consists of a cocktail of the hybridization
solution without the specific probe to exhaust possible
nonspecific bonding sites prior to incubation of the
specific probes.
Additional pretreatment using
levamisol, normal rabbit serum, etc. can also be performed to prevent the subsequent detection step causing
any background. The samples are then equilibrated in
a solution that is close to the hybridization condition [37)
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destroy the unhybridized single-stranded probes with
RNase, further reducing the background.
A large
amount of the same kind of probe can be generated.
However, the preparation of riboprobes requires the
availability of the appropriate cDNA, considerable
experience with molecular biological skills to prepare
and propagate the plasmids and transcripts, and an
RNase-free environment for probe preparation and
handling. It is more specific than the shorter oligoprobes. A good riboprobe can bind its complementary
mRNA more tightly than the shorter oligoprobes allowing for more stringent washing, which can lead to lower
backgrounds and a more specific detection of the target.

duced nonspecific binding, and is preferred by many
investigators. Fluorescein can yield very high signal-tonoise ratios and detecting sensitivities, and therefore has
been widely used in chromosomal labeling, and often
goes by the acronym FISH (Fluorescence In Situ Hybridization) [48, 69, 93].
Optimizing in situ Conditions

The search for optimal condition for hybridization
is one of the key issues for successful experiments. It
is important to determine the melting temperature at
which 50 % of the double-stranded sequences are denatured. Equations are available for different factors that
govern the relationship between the two complementary
sequences in the denaturing and reannealing processes.
Generally for ideal hybridization, the reannealing
temperature should be set to 20-25°C lower than the
melting temperature to generate a stable hybridization
product. To ensure specificity for shorter probes, the
hybridization temperature may be adjusted at 12-17°C
below the melting point. The optimal hybridization
temperature should be established empirically in addition
to being predicted from the formulas. A temperature
range of 37-42°C is a good starting point for the hybridization step. This is derived from inclusion of 50 %
formamide in the hybridization solution which competes
with bases for the formation of hydrogen bonds and
thus lowers the temperature requirement. For a DNA
sequence with 50 % C-G contents in 0.4 M sodium
chloride containing 50 % formamide, the melting temperature is about 54.5°C, and the hybridization temperature
is adjusted to 37-42°C. The concentration of a probe is
also important. It is usually used at around 300 ng/m1
with a range of 200-1500 ng/m1 depending on the size of
the probes. The hybridization kinetic is also affected by
salt concentrations. At concentrations below 1.5 M, the
higher the salt concentration, the higher the rate of
hybridi:z.ation. Polymers of high molecular weight, such
as dextran sulfate and polyethylene glycol, are often
added at a concentration of about 10% (v/w). Those
molecules can create a networking phenomenon, taking
up sufficient space in the solution to artificially increase
the probe concentration and thus the hybridi:z.ation rate
by about tenfold without creating any noticeable side
effects [1,2]. The washing solution should be designed
to contain the appropriate salt content that will wash
away unbound probes and probes in less stable, mismatched hybrids, and leave the perfectly-matched
hybrids intact. To set up an in situ hybridization
protocol for a new target, the best approach is to follow
previously established procedures and then adjust the
various conditions, one at a time, starting from the
probe design, hybridi:z.ation solution and incubation

Oligoprobes

Oligoprobes (or oligoprimers) are small singlestranded probes that possess many advantages [43]. The
simplicity in manufacturing those probes make them an
easy choice for in situ hybridization. If the target
sequence is known, oligoprobes can be synthesized with
a DNA synthesizer or ordered from a molecular biologic
reagent company at a reasonable cost. The length of an
oligoprobe should be about 14-50 bases [80]. The
sequence has to be unique to the target of interest so that
unwanted hybridization will be minimized. The percent
of G and C content is also important as this will affect
the thermostability of the hybrid or the background
labeling. Optimal conditions for individual probes and
targets should be established empirically, particularly for
oligoprobes, as the window for optimal hybridization is
narrower than for longer probes.
Probe labeling

A variety of molecules have been used to label
probes. Radioisotope labeling remains the most sensitive approach. 35 S and 33P have been a good compromise for probe labeling as they do not require too long
an exposure time for autoradiography and give relatively
high resolution. These labeling methods are widely used
because of their sensitivity and reliability [47, 64].
Non-radioisotope labeling has become increasingly
popular and, with refinement of the technique, more
sensitive [29, 58, 76]. These methods avoid the hazardous radioisotope handling and disposal, shorten the
experimental protocol, and yield high resolution results
that can be combined with other techniques such as
immunohistochemistry. It is also suitable for in situ
hybridization at the electron microscopic level when
used in combination with immunogold labels. Commonly used labeling molecules include biotin, digoxigenin,
alkaline phosphatase, hapten and fluorescein. Biotin
enjoys the popularity because of the availability of a
wide variety of detection kits. Digoxigenin is a plant
molecule that can be recognized by specific antibodies,
providing added specificity and sensitivity due to re30
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temperature. Changing probe design is often the most
effective measure to make in situ hybridization work.

Transcription of the target mRNA is achieved by adding
reverse transcriptase and labeled nucleotides which allow
the synthesis of a labeled complementary DNA (cDNA).
Since the synthesired cDNA remains associated with its
mRNA template as a cDNA-mRNA hybrid, anatomical
distribution and cellular localization are preserved, thus,
it is one of the main advantages of 1ST.
In the original works [67, 87), radio labels were
used and the localization of the labeled cDNA was
detected by autoradiography. Many non-radioactive
detection systems have been developed for ISH and can
be applied to 1ST, i.e., fluorochrome-labeled dNTPs in
fluorescence methods [6, 7, 52, 65, 66, 89, 93), biotinlabeled [26, 39, 50, 53, 55, 59, 65, 73, 74] or digoxigenin-labeled [19, 20, 36, 39, 79, 91, 92] dNTPs in
immunochemical detection methods.
One of the first applications of the 1ST technique
was to the localization of proopinmelanocortin (POMC)
mRNA on fresh-frozen paraformaldehyde-fixed sections
of rat pituitary using reverse transcriptase and radiolabeled 3H-dCTP in the cDNA elongation process
followed by autoradiography [87].
In another early
study, 1ST was applied to localired alpha-2 domain of
CD la mRN A using an oligonucleotide primer specific to
the target mRNA, incorporating 35S-dCTP into cDNA
followed by autoradiography [67]. 1ST has also been
used to investigate the temporal expression of mRNAs
in developing embryos [22, 23). One of the most
intriguing uses of 1ST was in the analysis of gene
expression in live cells where mRNA in single live
neurons in vitro was injected with primer, dNTPs, and
reverse transcriptase via whole cell patch electrode. The
contents of the cell was then harvested by suction back
into the electrode, the electrode incubated in vitro where
the cDNA is first synthesired by 1ST followed by
replication of cDNA to many copies of amplified RNA
(aRNA) [90]. The aRNA was assessed by Southern and
Northern blot analysis.
More recently 1ST has been
used to localize -y-GTP mRNA in paraffin section from
rat kidney [91] and from cell cultures of rat brain microvessels [92].
One technique closely related to 1ST for mRNA is
termed, PRimed in situ labeling (PRINS), which was
first used by a Danish group to localize chromosomal
DNA [52-55], and was later confirmed by a group in
Scotland [26, 73). For clarity, the PRINS technique
applied to DNA is referred to as PRINS-DNA. The
PRINS-DNA procedure uses unlabeled DNA probes or
oligonucleotides as the primer, and DNA polymerase
(Kienow or Taq-1) and biotin or digoxigenin labeled
dNTPs to synthesize labeled DNA in situ. The site of
synthesis was detected by immunocytochemistry using
fluorochromes as reporter molecules. A variation of
PRINS-DNA can be used in the detection of mRNA [54,

In situ Hybridization
Technically in situ hybridization is a well established
method. The protocols are fairly straight forward.
When the right probes are selected and the target
sequences are preserved and accessible, the properly
executed hybridization procedure should lead to clear
and well defined signals with low background. The
window of opportunity for achieving optimal reaction is
fairly broad. Certain small mishaps in performing the
technique would not lead to unusable results.

Advantagesof ISH
One of the advantages of in situ hybridization, in
comparison to in situ transcription and in situ PCR, is
that the probes are hybridired to the target DNA or
RNA sequences directly without target manipulation or
amplification. What are amplified in the in situ hybridization protocols are the labeling molecules not the
targets themselves. Therefore, there is little problem of
product diffusion or amplicon back diffusion, sometimes
a formidable problem for in situ PCR. In addition,
when the signal amplification steps are constant, the
amount of reporting signals are approximately proportional to that of the target, thus allowing semiquantitative
assessment of the target DNA or RNA. When evaluated
jointly with the results obtained with immunocytochemistry, this semiquantitative information can lead to meaningful interpretations of the cellular components under
study. For example, they may indicate the balance or
imbalance of the expression of a particular gene and the
production of the coded protein. When the distributions
and relative quantities of the gene expression and its
protein are different, certain cellular events could be
indicated [29, 86, 88].

Disadvantagesof ISH
The disadvantage of in situ hybridization is that it is
not as sensitive as in situ PCR, or in situ transcription.
Nevertheless, with the newly reported, more powerful
signal enhancement techniques such as the nanogoldsilver immunostaining and computer enhanced fluorescence in situ hybridization, the detecting sensitivity of in
situ hybridization has been improved markedly [35, 69,
78].

In situ Transcription
1ST is initiated by the hybridization of a primer
(usually a specific oligonucleotide) to target mRNA in a
tissue section or cell preparation on a glass slide as is
done in conventional ISH [18, 38, 50, 62, 63, 65, 66].
31
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74], and when applied to mRNA it is referred to as
PRINS-mRNA. PRINS-mRNA is virtually the same as
IST in that it uses an unlabeled primer complementary
to a specific mRNA sequence, and reverse transcriptase
and labeled dNTPs to synthesize a labeled cDNA. Thus
all comments made about IST should also apply to
PRINS-mRNA.

virus infections and studying the pathogenesis of many
viral and oncogenic diseases [28, 78].
In situ PCR can be performed in several different
ways. It can directly incorporate labeling molecules into
amplified products by using labeled primers or labeled
free nucleotides in PCR.
This way, all amplified
sequences have the labeling molecule built into them for
subsequent detection. The amplified sequence can also
be detected by employing in situ hybridization with a
labeled probe complementary to the amplified target.
RNA can be reverse transcribed into cDNA and then
amplified and detected. Several in situ PCR machine
models are available on the market. Each has its
advantages and limitations.
It is well recognized that the key steps in in situ
PCR include tissue preparation, pretreatment, primer
and probe design, washing and detection. However, the
prevention of amplified product diffusion is perhaps the
most important consideration in designing any in situ
PCR protocol. This technique is relatively new and
technically challenging. False positivity and negativity
can occur easily and should be carefully checked with a
number of control experiments, including positive and
negative tissue samples, and omission of primer, probe
or other key components, one at a time, in the amplification or detection mixtures. The ISPCR results should
be compared with results obtained by liquid phase PCR
using the same primers and probes to detect the same
sequences on DNA or RNA extracts from the same
tissue samples.

Advantages of 1ST
Since chain elongation is independent of the length
of the primer, oligonucleotide primers induce as much
(if not more) labeling of the target mRNA than a much
longer pre-labeled probe, thus increasing the sensitivity
of the method. Another advantage of IST is its application to the detection of minor sequence variations in
RNA by the proper selection of the sequence; thus, the
position of the primer can control whether or not there
will be chain elongation. The application of IST to the
detection of minor sequence variations should be superior to ISH in that it is well known that the last few
nucleotides of the primer are crucial to the initiation of
chain elongation [10]. A significant technical advantage
of the method is that the probe (primer) is unlabeled and
labeling occurs only secondarily to specific hybridization, and the unincorporated labeled nucleotide can be
washed away easier, which results in a lower background. In addition, fewer procedural steps allow for a
shorter cumulative incubation time resulting in less
degradation in the tissue morphology which often
accompanies ISH or ISPCR. Another advantage of the
milder conditions of IST is that it allows for the detected
mRNA in cell suspension intended for flow cytometry
without clumping and disintegration of cells [4].

Advantages of ISPCR
The most obvious advantage of in situ PCR is, of
course, its very high detecting sensitivity while retaining
tissue morphology so that minute quantities of DNA or
RNA can be visualized and correlated to the surrounding
morphology. It was reported that it can detect down to
a single copy of a DNA or RNA sequence in intact cells
or on tissue sections. This makes it a very valuable tool
for many purposes, especially the detection of early or
latent viral infections or early genetic changes in oncogenesis. All these can be achieved with commonly used
enzyme labeling methods and viewed with a transmitting
light microscope. The detecting sensitivity of conventional in situ hybridization is not entirely clear, but is
believed to need at least 20 copies for detecting and thus
leaves a technical gap where in situ PCR finds most of
its applications. A second advantage is, in theory, in
situ PCR can be combined with other methods to
demonstrate two targets simultaneously on the same
tissue preparation. It can also be performed at the
electron microscopic level, although the preliminary
reports in this regard (mostly in abstract forms) showed
very poor ultrastructure preservation. A third advantage,

Disadvantages of 1ST
The main disadvantage of IST is that it requires a
high copy number of target mRNA (or DNA). If the
copy number is low, ISH may be the technique ~f
choice. If the copy number is very low, then ISPCR 1s
the technique of choice, and has been shown to be able
to detect a single copy. See ISPCR below.

In situ PCR
In situ PCR combines the DNA amplifying power
of liquid phase PCR with the localizing capability of in
situ hybridization [28, 63]. First, it amplifies minute
quantities of DNA or RNA fragments to millions or
billions of identical copies at the site of the original
template and then detects or visualizes the amplified
signal in situ. This technique fills a technical gap and
allows detection of low copy numbers of nucleotide
sequences against the background of tissue structure,
even detecting a single copy of DNA or RNA per cell
[78]. ISPCR is particularly important in detecting latent
32
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it has been reported [44), although rarely noted in the
literature, that a small number of antisense sequences
may be produced by the target cells, possibly by a
mechanism of transcription regulation. Therefore, a
sense probe may result in a reduced but still specific and
positive labeling. We have observed this phenomenon
and learned to interpret the sense probe results with
caution [29). Using an unrelated probe of the same
length and C + G content is the best way to get around
this problem. Positive controls may include a tissue
preparation with a known quantity and distribution of the
target sequence. Negative controls may include a piece
of tissue that is known not to contain the target sequence. This can be created artificially by treating the
tissue sections with RNase or DNase to destroy the
target sequences. However, this needs to be performed
carefully and followed by extensive washing. Any trace
residue of the enzyme that finds its way into the real
experiments may destroy the target or probe. Additional
controls may include the omission of each of the key
elements in the incubation cocktails. This is often
effective in checking the ingredients that cause the false
positivity or give high background. It is always advisable to perform Southern or Northern blot analysis on
DNA or RNA extracts of the same target tissue side-byside with in situ hybridization to verify the presence and
quantity of the target sequences. The specificity of the
visualization methods also needs to be checked including
replacement of each of the key elements, particularly the
primary antibody or the first linking reagent to the
probe. Only after the key controls give the expected
results can the observations with in situ hybridization be
validated.
It should be noted that new techniques are emerging
that can detect low copy numbers of DNA and RNA
without going through the elaborate in situ amplification
steps. The reporting signals can be amplified instead of,
or in addition to, the amplification of the target sequences themselves.

again in theory, is that direct in situ PCR can detect
DNA or RNA targets without knowing the entire
sequence by using a pair of primers flanking the two
ends of the target. Overall, in situ PCR has a high
detecting sensitivity that has made in situ PCR so
popular.

Disadvantages of ISPCR

In comparison with in situ hybridization and other
highly sensitive methods, in situ PCR has a number of
disadvantages. First, it is technically challenging to set
up reliable in situ PCR and, once set up, the technique
is often not very stable. This is due primarily to the
large number of critical steps in the protocol. These
include adequate enzyme digestion, efficient amplification, prevention of amplicon diffusion, and reduction of
background.
It often takes longer and needs more
controls to establish reliable in situ PCR protocols. The
second disadvantage is that the tissue morphology is less
than ideal. Because of digestion and, in particular, the
harsh treatment by the thermal cycling, the morphology
of the samples, although still recognizable, is often
distorted and damaged. The third disadvantage is that
the protocol of in situ PCR requires specially designed
machines which makes it more expensive and less
convenient to perform. Fourth, because of the very high
detecting sensitivity, the less than desirable morphology
and the potential problems associated with amplicon
diffusion and inadequate digestion or washing, the
results could be difficult to interpret. Extensive controls
are sometimes called for and this might make the
experiment lengthy and less manageable. Strict internal
and external controls are needed for in situ PCR;
however, optimal control kits are not currently available
for this technique.
It should be mentioned that although in situ PCR is
a very powerful and attractive technique, it is not the
only one for detecting low copy number of nucleotide
fragments. Other procedures such as FISH, nanogoldsilver method, 3-SR technique, radioisotope labeled in
situ hybridization, and autoradiography, etc., can also
detect those sequences without some of the drawbacks of
in situ PCR. Each of the methods has it strengths and
weaknesses and should be considered before committing
a given in situ PCR protocol.

EM in situ hybridiution

In situ hybridization has been applied at the electron
microscopical levels using electron-opaque labels [25].
The attempts of applying in situ PCR at the EM level
have not been very successful because of the deterioration of the ultrastructure caused by the many PCR
cycles, although signals have been reported to be
visualized under the electron microscope.
Both preembedding and postembedding in situ
hybridization can be performed on electron microscopic
grids. The procedure is similar to that for the light
microscope except that the protocols are adjusted to the
EM conditions with much gentler digestion and washing.
Colloidal gold remains to be the best labeling method at

Controls
As for immunohistochemistry, it is extremely
important to perform adequate controls to verify the
specificity of in situ hybridization [14, 16, 58, 63, 75].
For single-stranded probes, a common approach is to
use a sense instead of antisense probe as a negative
control and follow the exact same protocol. However,
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the electron microscope level. A double labeling with 2
differently sized gold particles can be performed on the
same grid to demonstrate the RNA or DNA and its
corresponding protein simultaneously, greatly facilitating
the morphological elucidation of the subcellular regulatory mechanism of a particular gene and its product [25].
Technically, EM in situ hybridization is quite
challenging. The tissue samples are very delicate and
the optimal balance of the many treatments, washings
and reactions need to be established empirically for each
target sequence in its host tissue. For detailed protocols,
readers are referred to a monograph on this topic edited
by Morel [75].

tion, washing in DEPC-treated water, etc.
2. Digest tissue with Proteinase K, 5-30 µglml at
37°C for 10-30 min in humid chamber.
3. Wash in DEPC-treated water for 3x2 min.
4. Deactivate Proteinase K at 70-75°C for 1 mm
(optional) wash in double distilled water 5 mins.
5. Prepare prehybridization solution (for 1 ml):
50% Dextran sulfate
250 µI
20xSSC
149 µI
EDTA (1 mM)
120 µI
Herring Sperm DNA
33 µI
DEPC-treated water
448 µI
6. Apply prehybridization solution to tissue section
and incubate at 42°C for 30 min.
7. Prepare hybridization solution with biotinylated
probe.
Hybridization solution (H.S.) (for 1 ml):
50 % Dextran sulfate
250 µI
EDTA (i mM)
120 µI
20xSSC
100 µI
Formamide
450 µI
Herring Sperm DNA
33 µI
DEPC-treated water
47 µI
Mix well and add probe. Probe final concentration: 0.2 - 1.5 ng/ µI.
8. Apply hybridization solution.
9. Incubate 3 hours to overnight at 42°C in humid
chamber.
10. Wash in 5x SSC for 5 min.
11. Wash in 2x SSC for 5 min.
12. Proceed to detection with a biotin detection kit
with sufficient background blockage.
13. Wash in distilled water (2x5 min).
14. Counterstain and mount.
Notes to Protocol #1
J. Radioisotope or digoxigenin-labeled in situ
hybridization can be more sensitive than biotin-labeled
in situ hybridization.
2. The probe in the hybridization solution (step 8)
can be heated to 95°C for 5 mins before being applied
to the tissue section to eliminate any self-annealing or
secondary structure formation of the probes.
3. Up to step JO, the procedure should be performed
in a RNase-free manner.
4. The hybridization mixture can be applied on
dehydrated dry sections or on wet sections. If the latter,
there should be as little liquid remaining 011 the slides as
possible to avoid diluting the concentrations of the
ingredients in the hybridization solution.
5. For hybridization solution of less than 40 µl per
tissue section, a coverslip can be applied and sealed at
the hybridization step (step 9) to prevent evaporation.
6. RNase may be used in post hybridization treatment to remove single-stranded probes, thereby reducing

Protocols
Recommended protocols of in situ hybridization
The following protocols are selected from many
published procedures. They have been tested in our
own laboratories and found to be reliable and reproducible. The first is for RNA-RNA detection using riboprobe to detect mRNA. It has been successfully used to
detect c-myc, N-myc and L-myc gene expression in
small cell Jung cancers [31] and atrial natriuretic peptide
gene expression in the heart [30, 32]. The second
protocol uses oligoprobe that was labeled with FITC and
detected with a specific antibody to FITC. We used this
protocol to detect peptide mRN A including ANP,
neuropeptide Y (NPY), insulin and glucagon. These
protocols can be adapted to different purposes. They
should be adjusted individually with particular probes,
targets and tissues. The protocols rarely give optimal
results by just copying and switching from one probe or
target to another. Controls should always be performed
with the experiments to assist in trouble-shooting and
result interpretation. There is inconsistency in tissue
preparation, digestion, pretreatment, and detection
among the protocols. This was due to the fact that they
were developed in different laboratories by different
individuals. They have all worked well for their particular applications at the time of the studies.
Common materials and equipment. The equipment needed are incubation oven, adjustable precision
pipettes, glassware, glass slides, coverslips, etc. The
reagents and solutions needed are xylene, alcohol,
dextran sulfate, saline sodium citrate (SSC) (20x, 5x,
2x, lx), EDTA (1 mM), Tris-buffered saline (TBS) (50
mM Tris/RC!, 150 mM NaCl pH 7.6), alkaline phosphate substrate buffer (100 mM Tris/RC!, 50 mM
MgCJ 2 , 100 mM NaCl pH 9.0), formamide (HCONHJ,
Diethyl Pyrocarbonate (DEPC; Sigma, St. Louis, MO).
Protocol #1: in situ hybridization using biotinlabeled riboprobes on tissue sections.
1. Prepare tissue sections by dewaxing, rehydra-
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night.
15. Wash in running water for 5 min.
16. Counterstain and coverslip.
Notes to Protocol #2
1. In step #2, the enzyme activity can be stopped by
optionally heating to 70°C for 1 min. Generelly the
activity is stopped by dilution in the subsequent
washings.
2. Up to step 9, the procedure should be performed
in a RNase-Jree manner.
3. All the other notes described in Protocol #1 also
apply to Protocol #2.

background. This can be applied at 100 µ,glml RNase A
and 1 unitlµ,l RNase T1 for 30 mins at 37°C.
7. Counterstain should not mask or overshadow the
specific labeling.

Protocol #2: in situ hybridization using FITCLabeled oligoprobes on tissue sections.
1. Prepare tissue section by dewaxing, rehydration,
washing in DEPC-treated water, etc.
2. Digest tissue sections with Proteinase K at 5-30
µ,g/ml in 0.05 M Tris/HCI buffer pH 7.6 made with
DEPC-treated water, and incubate for 10-30 min at
37°c.
3. Immerse in DEPC-treated, double-distilled water
for 3 X 2 min.
4. Dehydrate in increasing grades of ethanol.
5. Air dry for 2 min.
6. Prepare hybridization solution with FITC-labeled
probe.

Recommended protocols of in situ transcription
Animals perfuse-fixed with 3 % paraformaldehyde
and 0.5 % glutaraldehyde in O.lM PBS (pbosphae
buffered saline), and the tissue embedded in paraffin by
standard procedures. Under RN Ase free conditions, 25nt oligonucleotide probes complementary to target
mRNA were hybridized 5 µ,m tissue sections, overnight.
The primed mRNA was then transcribed in situ by
incubation with a mixture of nucleotide precursors
containing DIG-labeled dUTP, and AMV (Avian Myeloblastosis Virus) reverse transcriptase. After washing the
in situ transcribed sections, the incorporated DIG was
bridged with sheep anti-DIG IgG, and detected with
10nm gold conjugated rabbit anti-sheep IgG followed by
silver enhancement. Controls consisted of the omission
of the oligonucleotide probes, or the substitution of
unrelated 25-nt oligonucleotides in the hybridization
step.
1ST has been applied to tissue, perfuse-fixed,
paraffin-embedded, and handled to permit 1ST, immunocytochemistry, and enzymecytochemistry on sections all
from the same paraffin block. This bas been illustrated
in detail by De Bault and Wang [19) using -y-Glutamyl
Transpeptidase (-y-GTP) in rat kidney to demonstrate the
localization of -y-GTP enzyme activity, -y-GTP protein,
and -y-GTP mRNA.
Common materials and equipment: The equipment needed is: incubation oven, hot plate, ice bucket,
adjustable precision pipettes, glassware, glass slides,
coverslips, etc. The reagents and solutions needed are
xylene, alcohol, sucrose, bovine serum albumin (BSA),
dithiotheitol (DTT), gum arabic, triton X-100, MgCl 2,
KC!, citric acid, sodium citrate, SSC (20x, 5x, 2x, lx),
EDTA (1 mM), TBS (50 mM Tris/HCI, 150 mM NaCl
pH 7.6), RNase inhibitor, Formamide (HCONHz),
DEPC, silver lactate or silver acetate, ice, etc.
Protocol #3: In situ transcription using unlabeled
oligoprimers and DIG-labeled dUTP on tissue sections.
1. Tissue was fixed in 3 % paraformaldehyde +
0.5 % glutaraldehyde + 2.5 % sucrose in 0.1 M PBS, pH

Hybridization solution
30 % Formamide
10 % Dextran Sulfate
0.6 M NaCl
Mix well and add probe. Probe concentration:
0.2-1.5 ng/µ,l, optimized for probe and
tissue sample selected.
7. Apply hybridization solution and coverslip.
8. Incubate 3 hours at 42°C in humid chamber.
9. Wash slides in TBS containing 0.1 % Triton-X100 for 3 x 3 min. Allow coverslips to drain off in the
washing solution - Do not touch coverslips to remove.
Dipping may be required to remove any remaining
coverslips.
10. Place slides on incubation tray and cover
sections with 100 µ,I of TBS, containing 3 % bovine
serum albumin, 0.1 % Triton-X-100, 20% normal rabbit
serum. Incubate for 10 min.
11. Tip off the blocking solution and add rabbit Fab
anti FITC conjugated to alkaline phosphatase diluted
1: 100 - 1:200 in TBS containing 3 % bovine serum
albumin and 0.1 % Triton-X-100. Incubate for 30 min 3 hours at 20°C.
12. Wash slides in TBS for 2 x 3 min.
13. Wash slides in alkaline phosphatase substrate
buffer pH 9.0 for 5 min.
14. Place slides in humid chamber and demonstrate
alkaline phosphatase activity by covering sections with
the following solution (for 200 µ,I):
80 µ,I 5-Bromo-4-chloro-3-indolylphosphate
(BCIP) - 50 mg/ml in dimethyl formamide
80 µ,I Nitro blue tetrazolium (NBT) - 75 mg/ml
in 70 % dimethyl formamide
10 µ,I 1 M levamisole
10 ml alkaline phosphatase substrate buffer
Color development may take from 1 hour to over-
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7.4, followed by standard paraffin embedding.
2. Tissue sections were dewaxed, rehydrated in a
graded ethanol series, and washed with 2xSSC (2xSSC
solution consists of 0.15 M NaCl, 0.015 M sodium
citrate, and adjusted to pH 7.0 with lN HCI). DEPCtreated water was used to make all solutions and buffers.
3. Each slide is incubated with 20 1-'l of ISH
mixture containing oligonucleotide primer(s) (covered
with a glass coverslip) at 42°C overnight, followed by
30 min incubation at room temperature.
The final
mixture contained:
50 % Formamide
4xSSC
0.02 % bovine serum albumin (BSA)

1 hr at room temperature. The final mixture contained
10nm gold conjugated Rabbit Anti-Sheep IgG diluted
1:10 in 1 % BSA in 0.02 M TBS.
15. Wash once with 1 % BSA in 0.02 M TBS, pH
8.2 for 10 min, followed by 3 washes of 0.05 M TBS
10 min each.
16. Wash with distilled water.
17. Incubate in Silver Enhancement mixture for
about 20 min at 22°C. The final mixture contained [34,
40]:
5.5 mM silver lactate or silver acetate
77 mM hydroquinon
120 mM citric acid
80 mM sodium citrate
10% gum arabic (see note #10 below for
Silver Enhancement Solution)
18. Wash with distilled water 5 times 2 min each.
19. Counter stain lightly with hematoxylin and eosin
(H&E) (optional).
20. Mount in Permount® and coverslip.

5 mM DTT
0.6U RNase Inhibitor/1-'l
101-'M Oligonucleotide (see notes #5 and #6
below for ISH solution)
4. Wash 2 times with 2xSSC and 2 times with
0.5xSSC, 15 min each at room temperature.
5. Hold slides in 0.5xSSC for 2 hr before proceeding with 1ST.
6. Each slide was incubated with 15 1-'l of 1ST
mixture containing DIG-labeled dUTP (covered with a
glass coverslip) at 37°C for 60 min followed by 45°C
for 10 min. The final mixture contained:
50 mM Tris-HCl, pH 7.4
6 mM MgCl 2
40 mM KC!

Notes to Protocol #3:
1. All reagents used and steps in the perfusion and
fuation procedure were perfonned at +4°C, unless
otherwise stated [45, 61].
2. In the standard paraffin embedding, infiltration
was by machine processing and included 2 changes of
95% Ethanol for 20 min each, 3 changes of 100%
ethanol for 15, 20, and 30 min respectively, 2 changes
of Xylene for 20 and 30 min respectively, all at 40°C,
and 2 changes of paraffin for 45 min each at 57°C. The
tissue is embedded in flat molds [70, 83}. Completion of
the entire embedding process 011 the same day that the
perfusionfuation is performed is important in maintaining maximum antigenicity and mRNA reactivity.
3. 5 1-'mparaffin sections were floated on a 0.1 %
DEPC-treated water bath at 42 °C, and picked up on
silanized slides [81}. It is important to perfonn the in
situ transcription and immunogold-silver staining or
other detecting procedures immediately after cutting; cut
sections stored for days or weeks lose reactivity and
background often increases.
4. All in situ reagents were prepared on ice and
used at the indicated temperatures [46, 74, 87].
5. Oligonucleotides were synthesized on an Applied
Biosystems, Inc. (Forest City, CA) Model 380B or 394A
according to the {3-cyanoethylphosphoramidite chemistry
method [12}. The newly synthesized oligo-nucleotides
were purified by reverse phase high pressure liquid
chromatography on a 4. 6 x 250 mm Cl 8 column (Rainin
Instrument Co., Woburn, MA) The column was equilibrated with 0.02 M triethylammonium acetate, pH 7.0;
and the elution was accomplished by a linear grad-ient
of 5% to 30% acetonitrile in 12 min. This typically
yields 100 pMl!,'l of 25-nt oligonucleotides [19].

5 mM DTT
0.02% BSA
0.1 mM DIG-DNA Labeling Mixture
0.6U RNase Inhibitor/1-'l
1U AMV Reverse Transcriptase/ 1-'l(see note #7
below for 1ST Solution
7. Wash 2 times with 2xSSC 30 min each at room
temperature.
8. Wash 2 times with 0.05xSSC 1 hr each at 35°C.
9. Wash 3 times with 0.05 M TBS pH 7.4 containing 0.25 % Triton X-100 10 min each at room temperature.
10. Slides were pre-incubated in 1 % BSA in 0.05 M
TBS for 15 min at room temperature.
11. Slides were incubated with 50 !,'I of 1 ° antibody
mixture at +4 °C overnight, followed by 1 hour incubation at room temperature. The final mixture contained
Sheep Anti-Digoxigenin antibody diluted 1:50 in 1 %
BSA in 0.05 M TBS.
12. Wash 3 times with 0.05 M TBS 10 min each
followed by wash with 0.02 M TBS pH 8.2 containing
0.25% Triton X-100 for 10 min at room temperature.
13. Incubate in 1 % BSA in 0.02 M TBS pH 8.2 for
15 min at room temperature.
14. Incubate with 50 1-'lof 2° antibody mixture for
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Total

6. Preparation of in situ Hybridization (/SH)
Solutions for step #3: A minimum of 20 µ,l of final /SH
working solution containing the oligoprimers is needed
for each slide. The following stock and final working
solutions are recommended:
Solution HJ
Formulation

Volumes Final Concentration

Deionized Formamide
20xSSC
J0mg/10 ml BSA
38.5mg/5 ml DIT

500
200
200
100

Total

µ,l
µ,l
µ,l
µ,l

* = Boehringer Mannheim Biochemica [13, 21, 33, 41,
84, 94].
8. In negative control slides the procedure was
modified by: a) omitting the /SH Oligonucleotide step
#3, b) omitting the DIG-DNA Labeling Mixture from 1ST
step #6, c) omitting the AMV Reverse Transcriptasejrom
!ST step #6, or d) a combination of these omissions.
9. ln the immunocytochemical detection of
Digoxigenin all immunoreagents were diluted with 1 %
BSA in 0.05 M Tris buffer saline (TBS) pH 7.4 [60, 87,
95].
IO. Preparation of Silver Enhancement Solutions:
In the silver enhancement step, a 100 ml final working
solution is prepared as follows:

50% Formamide
4xSSC
200µ,g BSA/ml
5mMDIT

1 ml

Solution H2
Take 160 µ,l of solution #1 and add 2.5 µ,l of 40Ulµ,l
RNase
Inhibitor
(Boehringer
Biochemica,
Mannheim, FRG) to give a total of JOOU in 162.5
µ,l. (Enough for 8 slides) [8-11].

Formulation

0.05M Tris-HCI pH 6.5
MgCli-6Hp (MW:203.3)
KCI (MW:74.55)
DIT (MW:154.3)
BSA
Total

Volumes Final
Concentration
40ml
48mg
120mg
31 mg
8mg

Volumes Final
Concentration

Solution HJ:

Solution HJ
Final working solutions: Makes 44 µ,l to 46 µ,l of
/SH mixture containing Oligonucleotide. Enough
for 2 slides when used at 20 µ,I/slide. Adjust volume
for additional slides.
7. Preparation of in situ Transcription (1ST) Solution: Prepare solution with cold reagents and hold on
ice until used. 15 µ,l of final working 1ST solution is
needed for each slide.
Solution HJ
Formulation

163.5 µ,l

6mM
40mM
5mM
200 µ,glml

Citric Acid, monohydrate
Sodium Citrate, dihydrate
Distilled Hp
Add 50% gum arabic
(in HP)

2.55 g
2.35 g
50ml

120mM
80mM

20ml

10%

Subtotal

70 ml

Solution H2
Hydroquinon
Distilled Hp

0.85 g
15 ml

Subtotal

15 ml

SolutionHJ
Silver Lactate
Distilled Hp

0.11 g
15 ml

Subtotal

15 ml

77mM

5.5mM

SolutionH4
Final Working Solution: First mix solutions #1 and H2,
just before use add solution #3. The final working
solution should be kept in the dark as much as possible,
i.e. , wrap working solution container and staining jars
with aluminum foil.

40 ml

Solution H2: Final Working Solution:
Solution HJ
140.0 µ,l
BM" DigoxigeninD NA Labeling Mix (J0X) 15.0 µ,l 0.lmM/base
BM RNase Inhibitor
(40Ulµ,l)
2.5 µ,l JOOU/163.5µ,l
BM AMV Reverse Transcriptase
(24Ulµ,l)
6.0 µ,l 150U/163.5µ,l

Recommended protocols of in situ PCR
The published protocols for in situ PCR and in situ
RT PCR are very different. Here we presented the
protocols for detecting HIV RNA and DNA as an
example to illustrate the techniques [96]. HIV ISPCR
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and HIV RT-ISPCR protocols take an average of three
full working days and follow the same guidelines of
other ISPCR methods. The same kits are used as for
conventional PCR and RT-PCR.
The technician's
schedule must be planned in advance. An ISPCR
laboratory should have a full-time and motivated staff.
Common materials and equipment. The equipment and reagents needed are identical to those for in
situ hybridization plus reagents, enzymes and probes
specified in the protocols. An in situ PCR machine is
also required. For our purposes, we employed the in
situ PCR Machine (PTC-100-16MS) for MJ Research
Inc. (Watertown, MA). Other in situ PCR machines
designed for slides can also be used.
Protocol #4: In situ polymerase chain reaction

parameters for ISPCR are 95°C 1.5 min (initial denaturing), 30 cycles of95°C (denaturing) 30 s, 55°C (annealing) 45 s, and 72°C (extension) 30 s. This is followed
by 72 °C (final extension) 1.5 min, and storage at 4 °C
(soaking).
9. The nail polish is softened with acetone and the
cover slips are carefully removed with a surgical blade.
Immediately, the sections are washed in 5x SSC, 2x
SSC and PBS for 5 min each.
10. Bake the sections in an oven at 60°C for 20
mm.
11. One hundred microliters of hybridization
solution are added to each section. Heat to 95°C, 5 min
for denaturing.
Avoid evaporation of the solution.
Hybridize overnight in a humid chamber at 45°C.

using HIV biotinylated probe on tissue sections.
Hybridization Solution
50 % formamide
25 % dextran sulfate
2x SSC
0.33 mg/mL salmon sperm DNA
HIV-1 biotinylated probe (SK19 or SK102 for
SK38/39 and SK145/43 l amplifications, respectively) at 250 to 400 pg/mL concentration.

1. Deparaffined tissue sections or cytological
samples are digested with 30 µglmL of proteinase K
solution, inside a humid chamber at 37°C for 15 to 30
rmn.

2. Wash sections in double-distilled (dd) HP for 10
min twice.
3. Place slides on a block at 70-75°C for 1 min to
inactivate the enzyme, followed by washing.
4. Prehybridize the sections inside a humid chamber
at 42°C for 30 min using 50 µL of a solution composed
of 12 % dextran sulfate , 2x SSC, 0.12 mM EDT A and
0.33 mg/mL salmon sperm DNA.
5. Remove the excess prehybridization solution from
each section and heat each of them to 75°C in a slide
thermocycler (MJ Research).
6. Slowly add 50µL of PCR mixture to each
section.

12. Wash the sections with 5x SSC, 2x SSC and
PBS for 5 min each.
13. Detection is performed using a kit for biotinylated probes (K600: DAKO, Carpenteria, CA) based
on the linkage of streptavidin and biotinylated alkalinephosphatase coupled to NBT/BCIP calorimetric reaction
(blue color).
14. Once the detection is completed, wash the
section in PBS for 5 min. If desired, slides may be
slightly counter stained with Pyronin-Y, Nuclear Fast
Red or Fast Green. These dyes should be dissolved in
2x SSC or PBS and not in ddHp.
15. Dry sections at 50°C in an oven and cover
using permanent mounting media.
Notes to protocol # 4.
1. In step # 1, the digestion time and temperature
vary according to type of specimen and must be empirically verified.
2. In step # 7, avoid excessive nail polish; otherwise, slides will not fit into the companments of the
thermocycler. Use the pipet tip to adjust the cover slips.
Bubbles trapped beneath the coverslip will usually come
out by themselves during heating. Therefore, do not try
to remove them by pressing the coverslip.
3. In step # 13, this reaction is carried out in darkness and monitored at about 15-min intervals under a
light microscope, usually for no more than 1 h.

PCR Mixture:

Volume

33.75 µL
ddHzO
lOx PCR Buffer II
5 µL
25 mM MgCl 2
5 µL
10 mM each dNTP
1 µL
25 mM each primer
1 µL
(SK38/39 or SK102/432)
5 U/mL Taq
DNA polymerase
0.25 µL

Final
Concentration

Ix
2.5 mM
200 µM each
0.5 mM each

1.25 U/50 µL

7. Cover each section with a glass coverslip one at
a time and completely seal the edges with an appropriate
amount of transparent nail polish. Keep all the slides at
75°C until the PCR mixture has been added to the last
one.
8. Start the thermocycling.
The temperature
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Protocol #5. Reverse transcriptase-in situ PCR
on tissue sections. Method A. Reverse transcriptasedriven RT-ISPCR.
1. Deparaffined tissue sections or cytological
specimens are digested with 30 µg/mL proteinase K
solution inside a humid chamber at 30°C for 15 to 30
min. Digestion process may be varied (see above).
2. Sections are washed twice in ddHp for 10 min
and heated to 70-75°C for 1 min to inactivate the
enzyme.
3. Sections are pretreated with RNase-free DNase.
Ten to twenty U/section incubating at 37°C for a
minimum of 4 h. Overnight incubation is strongly advised to completely destroy the DNA.
4. The sections are extensively washed with several
changes of ddH 20 for 20 min.
5. Ten microliters of RT mixture (GeneAmp RNA
PCR Kit) are added to each section and incubated inside
a humid chamber at room temperature for 15 min.

ddHp
Taq DNA polymerase
Primer SK38
Primer SK39
Total volume

MgCl 2
lOx Buffer II
ddH 2 0
dNTPs each
RNase inhibitor
Reverse transcriptase
Random hexamers
Total volume

Final
Concentration

2.0
1.0
1.5
1.0

5mM

µL
µL
µL
µL
0.5 µL
0.5 µL
0.5 µL
10.0 µL

lx
1 mM
1 U/10 µL
2.5 U/10 µL
2.5 µM

RT Mixture

Volume

6. Sections are incubated in a humid chamber at
42°c for 20 min.
7. Twenty microliters of prehybridization solution
(same as used for HIV ISPCR) are added to each
section.
8. Slides are placed in the slide thermocycler (MJ
Research) set with one cycle above 95°C for 3 min (to
inactivate the reverse transcriptase) and 5°C for 5 min.
9. Sections are incubated with the residual prehybridization solution in a humid chamber at 42°C for
20 min.
10. PCR mixture is added to the sections, 40
µLI section.

ddH 20
lOx RT Buffer
MnCl 2
dNTPs each
rTth DNA polymerase
"Downstream"
primer SK39
Total volume

Final
Concentration

2.0 µL
4.0 µL

2mM
lx

11.5 µL
2.0 µL
2.0 µL
0.4 µL
2.0 µL
1.0 µL
20.0 µL

lx
1 mM
200 µM
5 U/20 µL
0.75 µM

PCR Mixture

Volume
MgCl 2
lOx PCR buffer

Final
Concentration

6. Next the humid chambers containing the slides
are placed in a refrigerator at 4 °C to stop the reaction.
7. Ten microliters of 12 % dextran sulfate solution
containing 1 mg of glycogen are added to each section.
8. Eighty microliters of PCR mixture are added to
the sections.

PCR Mixture

Volume

1.25 U/50 µL
0.25 µM
0.25 µM

11. The amplification is performed in the slide thermocycler using the same parameters as for HIV ISPCR
(see above).
12. Hybridization and detection are also performed
as described in HIV ISPCR.
Method B. rTth DNA polymerase-driven RTISPCR
1. Deparaffined tissue sections or cytological
specimens are digested with 30µg/mL proteinase K
solution inside a humid chamber at 37°C for 15 or 30
rmn.
2. Sections are washed twice in ddH 20 for 10 min
and heated to 70-75°C for 1 min to inactivate enzyme.
3. RNase-free DNase pretreatment is performed as
described above.
4. Sections are extensively washed in ddHp for 20
mm.
5. Twenty microliters of RT mixture (Thermostable
rTth Reverse Transcriptase RNA PCR Kit; PerkinElmer) are added to each section and incubated inside a
humid chamber at 70°C for 25 min.

RT Mixture:

Volume

37.75 µL
0.25 µL
0.5 µL
0.5 µL
40 µL

39

Final
Concentration
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ddH 20
lOx Chelating buffer
MgC12
"Upstream"
primer SK38
Total volume

61.0 µ.L
8.0 µ.L
10.0 µ.L
1.0 µ.L
80.0 µ.L
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Authors: This depends on the size of the probe and the
target and how the probes are labeled. When the single
stranded and double stranded probes are the same size
and identically labeled, single stranded probes are more
efficient as they do not normally anneal to themselves.
In the case of a large target where large single stranded
probes are difficult to make, double stranded probes will
be superior. On the other hand, longer probes will find
less targets than shorter ones, thereby having decreased
detecting sensitivity but giving a more specific signal.

J (ed). Birkhauser Publishing, Boston, MA, pp. 77-98.

Discussion with Reviewers
Reviewer I: Among different fixatives which one would
you prefer for expression analyses of a particular gene
in the tissue sections?
Authors: 10 % formalin or 4 % paraformaldehyde in
0.01 M PBS adjusted to pH 7.4.

Reviewer II: In the section on trouble-shooting for in
situ hybridization, the authors state that probe design is
a very important factor. In my experience, nick translation and random primer usually give good results for
probe synthesis for any DNA template of > 500 hp.
Define probe design and explain its role in troubleshooting. In the case of no signal with in situ hybridization,
I would recommend that the investigator use his/her
labeling system and an alu DNA probe tern-plate, as the
repetitive alu sequence is present as thousands of copies
in mammalian cells. Do the authors agree with this
strategy or do they recommend some other method to
deter-mine the cause of a lack of signal with in situ
hybridization that involves changing probe design?
Authors: Probe design in this context refers to the
selection of a particular fragment of the sequence
complementary to the target and the length of this
sequence, rather than the way the probes are labeled. In
our experience, when experimenting with a new target,
repeated negative signals, even after modifying the
hybridization conditions, call for a new probe to a
different portion of the target. Certain probes work well
and others do not, i.e., either too faint a signal or too
much a background, even if, in theory, the new probe
should work equally well. This may have to do with the
degree of the uniqueness of the probe sequence and the
way the target sequences are folded and embedded in the
tissue sample, presenting different availability of the
target sequences to the particular probes selected. The
suggested alu DNA probe ternplet approach is a good
method to check the labeling efficiency, the general
hybridization conditions and target (alu sequences)
availability, but give little indication to the suitability of
the particular probe that gives weak or no signal. In
addition to employing the alu sequence, shifting the
target sequence or using a collection of different sequences to different or overlapping portions of the target
should be tested. By changing the probe design, i.e., to
use a different probe sequence, we have solved the
problems of false negative hybridization in a number
cases while other modifications produced little success.

Reviewer I: Would it be possible to amplify a particular
genetic element from a tissue section which has been
fixed in paraformaldehyde or formalin for longer period
of time like 5-10 years?
Authors: It is possible to amplify targets in formalin or
paraformaldehyde fixed archive tissue samples. One
example was reported by Isaacson et al. (1994) who
examined polio, measles, influenza and HTL V-1 in
archival brain tissue samples with in situ RT-PCR and
detected their RNA sequences in individual neurons, glia
and vascular endothelial cells. Some of the paraffin
tissue blocks were over 25 years old. However, it
should be pointed out that the degree of success with
archival material is dependent on the completeness of the
fixation and the nature of the target sequence.
Reviewer I: You mentioned that the concentration of
probes in the range of 200-1500 ng/ml depended on the
size of the probe. How does the size of the probe relate
to concentration, is it empirical or certain defined rules
that govern the concentration and size of the probe?
Authors: The concentration in this case was given in
ng/ml. At a given concentration, the larger the probe,
the fewer the number probes available per ml of solution. Thus, the concentration should be increased
proportionally with the increase in probe length to
ensure that a sufficient number of probes are available
for hybridization.
Reviewer II: The authors state that single stranded (ss)
DNA probes are superior to double stranded (ds) DNA
probes because they do not self-anneal. The hybridization signal's intensity ultimately reflects the number of
reporter nucleotides on the probe-target complex. For
a target of 8,000 base pairs (a small virus), a ds probe
can easily be made that covers this entire region; this is
much more difficult with the ss DNA probe. In my
experience ds DNA probes usually give the best results;
this is most notable with the ultimate small single
stranded DNA probe, i.e, the oligoprobe. Do the
authors have any direct experience showing that a ss
DNA probe is superior to a ds DNA probe and, if so,
would this be expected for large targets ( > 1000b)?

M. Malecki: Do you perform liquid phase PCR as a
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Reviewer II: With 1ST, one is making labeled cDNA
inside the cell. Do the authors know of instances where
this labeled product diffused out of the cell and into
another cell type known to not have the target?
Authors: We know of no published case where the
labeled cDNA product of 1ST diffused into another cell
type not containing the target sequence. In 1ST, the
cDNA is literally synthesized on the target sequence
creating a double stranded nucleic acid duplex with little
or no mismatched NTP pairs. Such double stranded
duplexes are very stable and require strong denaturing
conditions to separate the new cDNA from its complementary strand, i.e., high melting temperatures well in
excess of the 45°C used in the last 10 min of the
transcription step, high stringency conditions in excess
of 2xSSC at room temperature plus 0.05xSSC at 35°C.

way to optimize annealing temperature for a specific
target?
Reviewer I: Besides the critical parameters like Proteinase K, probes, and primers, do you think optimization
of annealing temperature is also critical, and if it is so,
how can one proceed with optimization of the system?
Authors: Optimization of annealing temperature is also
very important, of course. This can be established by
keeping the other factors constant and testing a number
of temperature settings. It can also be established by
liquid phase PCR with the same target and primers.
Nevertheless, the temperature should not vary too much
from target to target.
Reviewer II: Background signals with in situ hybridization are due to nonspecific sticking of the labeled probe
to cellular proteins and/or nucleic acids. That is, the
probe, which presumably enters all cells, will diffuse out
unless it finds its complementary target or non-specifically sticks to cellular components. From a practical
viewpoint, I would argue that the most likely causes of
background are: a) posthybridization wash not stringent
enough, where temperature is a key factor; b) probe
concentration too high. The questions are: 1) why do
the protocols not include a temperature for the post
hybridization wash. 2) Most protocols do not include a
prehybridization wash, which, in my experience, does
not affect background. Have the authors done comparative studies of background with and without prehybridization?
Authors: Background signals with in situ hybridization
are caused by nonspecific or less specific sticking of the
labeled probes to cellular proteins and/or nucleic acids
or may be trapped by cytoskeleton structures that in
theory can be removed by critical washing. Temperature, stringency of the washing solution, washing
duration and vigilance are all factors affecting the
efficiency of probe removal from the tissue sample.
Temperature is one of the factors that affect the outcome
significantly. We usually raise the temperature up to
50°C if the initial washing does not remove most of the
background staining. The optimal condition should be
established empirically for each case, therefore no
particular temperature is recommended. We have performed comparisons between protocols with and without
prehybridization washes and found that prehybridization
washing reduced background staining is some cases,
presumably by blocking potential nonspecific bonding
sites in the tissue sample. We also know that this
prehybridization washing does not affect the efficacy of
amplification nor does it increase background staining.
We routinely perform prehybridization washing for both
in situ hybridization and in situ PCR.

Reviewer II: The authors state that extensive washing of
the protease and DNAse is needed with in situ PCR.
However, in my experience, a 1 minute wash in water
and a 1 minute wash in 100 % ethanol is enough to
eliminate these enzymes. Have the authors demonstrated
any change in the in situ PCR signal relative to the
length of wash after one or both of these enzymes?
Authors: You may be right, but we prefer to be on the
safe side. When there are so many steps that can go
wrong we want to be sure that the experiments are not
ruined by easily avoidable mishaps at the beginning of
the protocol. We also know that extensive washing does
no harm to the targets and subsequent reactions.
Reviewer Il: The authors claim that one can make
millions of copies of the amplicon in the cell during in
situ PCR. However, most investigators report a 200+
fold increase in copy number, and not a million fold
increase. It would, on a theoretical basis, seem unlikely
that one could amplify one million copies in a space of
10µ, given the extremely high concomitant amplicon
concentration which is one of the limits on the extent of
amplification in a 100µ1 reaction volume. What is the
basis for the authors claim for such a marked increase in
copy number during in situ PCR?
Authors: It is true that PCR on tissue sections or intact
cells is not as efficient as liquid phase PCR due to the
limited accessibility of the target and the interference of
fixed tissue structures as well as the smaller amount of
solution (we add about 50-100 µI of PCR solution to the
slide depending on the size of the sample). But once a
sequence is amplified, more than a few hundred copies
will result within the next ten cycles. Nobody knows,
even roughly, how many copies of amplicons there are
after amplification in situ. It is difficult, if not impossible, to measure. By theory, the amplicons are free
floating and they diffuse out freely following each cycle
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of amplification, therefore leaving rooms for new
amplicons to form. We believe that the estimated 200
plus copies of the amplicons by others are not grounded.
One thing appears to be true, i.e, there are not too many
copies left in situ by the time the signals are examined
under the microscope. Judging by the intensity and the
size of the reporting signal, there should not be more
than a few hundred copies of the ampli-cons remaining
in their original location. Nevertheless, this does not
mean that only those amplicons are produced by the
PCR, as most of them have diffused or been washed
away. There is no reasonable mechanism to keep the
amplicons remaining in situ, except the possible long
amplicon theory proposed by one of the authors (JG) and
some possible trapping and network-forming phenomenon to hold the amplicons on site. We speculate that
most amplicons diffuse to the supernatant easily.

Reviewer I: Between the two in situ PCR strate-gies,
i.e., direct incorporation of labeled molecules into
amplified products or indirect labeling like addition of
labeled probe, which one is better and why? Would you
please comment on this?
Authors: We prefer the indirect methods, as do most
investigators. It has an added step to check the specificity. Since some nonspecific sequences are amplified in
PCR, they will not be picked up by the specific probes
in the hybridization step used in the detection system.
It should also be pointed out that in the indirect method,
nonspecific DNA repair, etc. will not affect the final
results. This has been discussed extensively in a number
of publications.
Reviewer II: An important measure of specificity with
ISH, 1ST, or in situ PCR is afforded by knowing which
cell type likely contains the target of interest. There is
often striking localization of the target to specific cell
types. An example would be parvoviral infections
where the target (the nucleated red blood cell) is easily
identified on morphologic grounds.
According to
published reports, with in situ hybridization and reverse
transcriptase (RT) in situ PCR, the signal only localizes
to the target cell, assuming a high stringent wash. If the
wash is not stringent enough, then other cell types show
signals with both methods. Explain why background
should be any more of a problem with in situ PCR
versus in situ hybridization, where an excess of probe
far greater than can be synthesized during the cycling
process is present, and why it is not evident in many
published reports of viral infection and in situ PCR
where the target cell is known?
Authors: This question has been partially answered in
a previous question ("The authors state that back diffusion .... "). To start with, in situ PCR is usually employed only after the conventional in situ hybridization
failed to detect any signal convin-cingly. The extremely
high detecting sensitivity of in situ PCR leads the
investigators to a new territory where more marginal
positivity may be present and positive signals may show
up in unexpected cell types. When those occur, extensive controls are called for and the new results may still
not be black and white. These all make the interpretation of the in situ PCR and, in particular, RT in situ
PCR results more difficult. For target mRNA, it is
often a matter of difference in quantity among different
cell types rather than a yes or no answer. We speculate
that when the target locations are known, the authors are
more confident to publish their results and the articles
are more likely to be accepted by journal referees. The
many, less than clear cut observations, even though they
may be closer to the truth, were buried in the lab's
notebooks and data bases.

Reviewer II: The authors state that back diffusion is a
formidable problem with in situ PCR. Back diffusion
would presumably be due to the large amount of labeled
amplicon in the overlying solution sticking to cellular
proteins and/or nucleic acids. This is equivalent to
every in situ hybridization reaction, where one has a
large amount of labeled DNA that can stick non-specifically to cellular components. This can be removed by
a high stringent wash, owing to the weak force of these
bonds versus the much stronger hydrogen bonds with
100% homology between probe and target. Explain why
back diffusion (background) is any more of an issue with
in situ PCR versus in situ hybridization.
Authors: The answer to this question is related to the
issue discussed in a previous question ("In the section on
troubleshooting ... "). In the situation of in situ PCR,
the concentrations of the amplicons are much higher than
that used for in situ hybridization, and increasingly so
until a plateau is reached. This large amount of amplicons will diffuse to other parts of the tissue sample and
may stick to them, semi-specifically or non-specifically
by bonding to proteins, or simply be trapped and tangled
at nonspecific sites. In addition, the variations in sizes
of the amplicons may "stick" to non-specific sites more
easily than the more uniformly sized probes in the
solution of in situ hybridization. More-over, the tissue
samples for in situ PCR tend to be more harshly treated
than those used in straight in situ hybridization. For
these reasons, the so-called back diffusion may be more
readily seen during in situ PCR than during in situ
hybridization. It should also be noted that back diffusion does not occur only with labeled amplicons, but
unlabeled amplicons produced in the so-called indirect in
situ PCR protocol can also cause nonspecific sticking
and subsequently be picked up by hybridization step
used in the detection process resulting in nonspecific staining.
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M. Malecki: Would you be able to estimate the distances between the target sequences and the reporter
molecules in ISH, 1ST, and ISPCR?
Reviewer III: Could you analyze differences in the
distribution of reporter molecules around the target
sequence labeled by 1ST and ISPCR as compared to
ISH?
Authors: The distances between target sequences and
reporter molecules in different methods depend on many
factors, including the size of the probes, the size of the
target, the type of tissue, the labeling methods, the
signal detecting methods, the visualization approach, etc.
It all depends on how much the targets have been
amplified and retained and what projection range the
reporter signal build-up has achieved by the particular
detecting method. It can range from the immediate
proximity as in 1ST, to a signal that can engulf the entire
cell by one target sequence in IS PCR. In general, in
situ hybridization gives more localized signals than the
other two techniques.

Additional Reference

Isaacson SH, Asher DM, Gibbs CJ, Gajdusek DC
(1994) In situ RT-PCR amplification in archival brain
tissue. Cell Vision 1: 84.

Reviewer I: In the HIV ISPCR protocol, prehybridization is recommended before doing actual ISPCR.
Does it provide certain (extra) advantage(s) for in situ
PCR amplification?
Authors: We routinely perform prehybridization for in
situ hybridization and find this step reducing background
labeling. For indirect in situ PCR, prehybridization is
also necessary. We perform this step before the PCR
cycles rather than afterwards, i.e., directly before the
subsequent in situ hybridization. This way, we avoided
the prehybridization step between the PCR cycles and
the hybridization step and believe that this is beneficial
for preventing diffusion of or washing away the amplicons from their original sites.
Reviewer I: In the HIV ISPCR protocol, in step #9
acetone is recommended for softening of nail polish.
Most people use absolute ethanol for this purpose. Do
you think acetone is better over ethanol?
Authors: It is our preference. Both will work. We
have not made a systematic comparison.
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